MeiraGTx Holdings plc Capital Expenditures
MeiraGTx Holdings plc (MGTX) reported Capital Expenditures of $2.34 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- MeiraGTx Holdings plc payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $332.00K, a 73.10% decline year-over-year.
- MeiraGTx Holdings plc payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $2.01M, a 17.43% increase year-over-year.
- MeiraGTx Holdings plc payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $272.00K, a 77.67% decline year-over-year.
- MeiraGTx Holdings plc payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $610.00K, a 16.44% decline year-over-year.
- MeiraGTx Holdings plc payments to acquire property, plant, and equipment for fiscal 2025 was $3.83M, a 22.79% decline from fiscal 2024.
- MeiraGTx Holdings plc payments to acquire property, plant, and equipment for fiscal 2024 was $4.96M, a 75.44% decline from fiscal 2023.
- MeiraGTx Holdings plc payments to acquire property, plant, and equipment for fiscal 2023 was $20.17M, a 55.13% decline from fiscal 2022.
- MeiraGTx Holdings plc payments to acquire property, plant, and equipment for fiscal 2022 was $44.96M, a 2.99% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $332.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.34M 10-Q · filed 2026-08-13 | $2.61M derived: sum of 3 quarters · filed 2026-08-13 | $3.22M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $2.01M 10-Q · filed 2026-05-14 | $2.28M derived: sum of 2 quarters · filed 2026-05-14 | $2.89M derived: sum of 3 quarters · filed 2026-05-14 | $4.12M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $882.00K derived: sum of 2 quarters · filed 2026-03-30 | $2.12M derived: sum of 3 quarters · filed 2026-08-13 | $3.83M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $610.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.84M derived: sum of 2 quarters · filed 2026-08-13 | $3.55M 10-Q · filed 2025-11-13 | $4.77M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.94M 10-Q · filed 2026-08-13 | $4.16M derived: sum of 3 quarters · filed 2026-08-13 | $4.89M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $1.71M 10-Q · filed 2026-05-14 | $2.93M derived: sum of 2 quarters · filed 2026-05-14 | $3.66M derived: sum of 3 quarters · filed 2026-05-14 | $4.99M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.95M derived: sum of 2 quarters · filed 2026-03-30 | $3.28M derived: sum of 3 quarters · filed 2026-03-30 | $4.96M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.06M derived: sum of 2 quarters · filed 2025-11-13 | $3.74M 10-Q · filed 2025-11-13 | $6.77M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $3.01M 10-Q · filed 2025-08-14 | $6.04M derived: sum of 3 quarters · filed 2025-08-14 | $9.60M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $1.68M 10-Q · filed 2025-05-13 | $4.71M derived: sum of 2 quarters · filed 2025-05-13 | $8.27M derived: sum of 3 quarters · filed 2025-05-13 | $13.25M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $6.59M derived: sum of 2 quarters · filed 2025-03-13 | $11.57M derived: sum of 3 quarters · filed 2025-03-13 | $20.17M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | $3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $8.54M derived: sum of 2 quarters · filed 2024-11-13 | $17.14M 10-Q · filed 2024-11-13 | $25.64M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $4.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $13.58M 10-Q · filed 2024-08-12 | $22.07M derived: sum of 3 quarters · filed 2024-08-12 | $32.08M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $8.61M 10-Q · filed 2024-05-09 | $17.10M derived: sum of 2 quarters · filed 2024-05-09 | $27.11M derived: sum of 3 quarters · filed 2024-05-09 | $41.11M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $8.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $18.50M derived: sum of 2 quarters · filed 2024-03-15 | $32.50M derived: sum of 3 quarters · filed 2024-03-15 | $44.96M 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | $10.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $24.01M derived: sum of 2 quarters · filed 2023-11-14 | $36.47M 10-Q · filed 2023-11-14 | $60.84M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $26.46M 10-Q · filed 2023-08-10 | $50.83M derived: sum of 3 quarters · filed 2023-08-10 | $62.73M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $12.46M 10-Q · filed 2023-05-11 | $36.83M derived: sum of 2 quarters · filed 2023-05-11 | $48.73M derived: sum of 3 quarters · filed 2023-05-11 | $54.31M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $24.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $36.27M derived: sum of 2 quarters · filed 2023-03-14 | $41.85M derived: sum of 3 quarters · filed 2023-03-14 | $46.35M 10-K · filed 2023-03-14 | ||||
| 2021-09-30 | $11.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $17.48M derived: sum of 2 quarters · filed 2022-11-10 | $21.98M 10-Q · filed 2022-11-10 | $30.00M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $5.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $10.08M 10-Q · filed 2022-08-11 | $18.09M derived: sum of 3 quarters · filed 2022-08-11 | $24.05M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $4.50M 10-Q · filed 2022-05-12 | $12.52M derived: sum of 2 quarters · filed 2022-05-12 | $18.47M derived: sum of 3 quarters · filed 2022-05-12 | $21.39M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $8.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $13.97M derived: sum of 2 quarters · filed 2022-03-10 | $16.89M derived: sum of 3 quarters · filed 2022-03-10 | $20.92M 10-K · filed 2022-03-10 | $20.92M 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $5.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $8.87M derived: sum of 2 quarters · filed 2021-11-10 | $12.91M 10-Q · filed 2021-11-10 | $12.91M 10-Q · filed 2020-11-05 | $17.66M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $6.95M 10-Q · filed 2021-08-11 | $6.95M 10-Q · filed 2020-08-06 | $11.70M derived: sum of 3 quarters · filed 2021-08-11 | $13.73M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | $4.04M 10-Q · filed 2021-05-11 | $4.04M 10-Q · filed 2020-05-07 | $8.79M derived: sum of 2 quarters · filed 2021-05-11 | $10.81M derived: sum of 3 quarters · filed 2021-05-11 | $11.90M derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $6.77M derived: sum of 2 quarters · filed 2021-03-11 | $7.87M derived: sum of 3 quarters · filed 2021-03-11 | $8.98M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.12M derived: sum of 2 quarters · filed 2020-11-05 | $4.23M 10-Q · filed 2020-11-05 | $13.12M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $2.21M 10-Q · filed 2020-08-06 | $11.09M derived: sum of 3 quarters · filed 2020-08-06 | $12.15M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $1.12M 10-Q · filed 2020-05-07 | $10.00M derived: sum of 2 quarters · filed 2020-05-07 | $11.06M derived: sum of 3 quarters · filed 2020-05-07 | $11.16M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $8.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $9.94M derived: sum of 2 quarters · filed 2020-03-11 | $10.05M derived: sum of 3 quarters · filed 2020-03-11 | $11.26M 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.16M derived: sum of 2 quarters · filed 2019-11-07 | $2.37M 10-Q · filed 2019-11-07 | $4.52M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $107.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.32M 10-Q · filed 2019-08-07 | $3.46M derived: sum of 3 quarters · filed 2019-08-07 | $7.03M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $1.21M 10-Q · filed 2019-05-14 | $3.36M derived: sum of 2 quarters · filed 2019-05-14 | $6.92M derived: sum of 3 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $5.71M derived: sum of 2 quarters · filed 2019-03-26 | $10.54M 10-K · filed 2019-03-26 | |||||
| 2017-09-30 | $3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $8.39M 10-Q · filed 2018-11-08 | ||||||
| 2017-06-30 | $4.82M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |